可先于溃疡性结肠炎临床诊断的新型粪便生物标志物
该研究对具有炎症性肠病风险的healthy个体进行粪便微生物组和功能分析,发现临床诊断UC前的粪便样本中蛋白水解活性和弹性蛋白酶活性已升高,且与特定菌群变化相关;无菌小鼠定植实验支持该蛋白水解特征具有功能意义,可能作为监测高危人群的非侵入性炎症标志物。
要点
- UC临床诊断前粪便蛋白水解和弹性蛋白酶活性已升高。
- 弹性蛋白酶活性与Adlercreutzia等潜在有益菌丰度负相关。
- 该蛋白水解特征可能作为高危人群的非侵入性监测标志。
核心结论
- 粪便蛋白水解活性升高先于UC临床诊断,并与肠道菌群变化相关,可能作为炎症的非侵入性生物标志物。
研究设计与样本
- 研究采用16S rRNA基因测序、鸟枪法宏基因组测序、体外功能实验和无菌小鼠定植,比较有IBD风险的healthy个体(pre-UC)、后续发展为UC者(post-UC)及匹配healthy对照(HC)的粪便样本。
主要发现
- post-UC样本微生物组成与HC和pre-UC样本不同,但功能分析显示UC发病前粪便蛋白水解和弹性蛋白酶活性已增加。
- 宏基因组鉴定出超过22,000个基因家族在HC、pre-UC和post-UC样本间显著不同,其中237个与蛋白酶和肽酶相关。
- 弹性蛋白酶活性与Adlercreutzia及其他潜在有益类群相对丰度负相关,与Bacteroides vulgatus等已知蛋白水解类群正相关。
- 从粪便样本分离的Bacteroides菌株中证实高弹性蛋白酶活性。
- 定植pre-UC菌群的无菌小鼠或其子代较定植HC菌群的小鼠粪便蛋白水解活性更高且炎症免疫基调更强。
临床怎么用
- 粪便蛋白水解特征可能用于监测UC高危人群,并可能成为抗蛋白酶治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Altered gut microbiota composition and function have been associated with inflammatory bowel diseases, including ulcerative colitis (UC), but the causality and mechanisms remain unknown. METHODS: We applied 16S ribosomal RNA gene sequencing, shotgun metagenomic sequencing, in vitro functional assays, and gnotobiotic colonizations to define the microbial composition and function in fecal samples obtained from a cohort of healthy individuals at risk for inflammatory bowel diseases (pre-UC) who later developed UC (post-UC) and matched healthy control individuals (HCs). RESULTS: Microbiota composition of post-UC samples was different from HC and pre-UC samples; however, functional analysis showed increased fecal proteolytic and elastase activity before UC onset. Metagenomics identified more than 22,000 gene families that were significantly different between HC, pre-UC, and post-UC samples. Of these, 237 related to proteases and peptidases, suggesting a bacterial component to the pre-UC proteolytic signature. Elastase activity inversely correlated with the relative abundance of Adlercreutzia and other potentially beneficial taxa and directly correlated with known proteolytic taxa, such as Bacteroides vulgatus. High elastase activity was confirmed in Bacteroides isolates from fecal samples. The bacterial contribution and functional significance of the proteolytic signature were investigated in germ-free adult mice and in dams colonized with HC, pre-UC, or post-UC microbiota. Mice colonized with or born from pre-UC-colonized dams developed higher fecal proteolytic activity and an inflammatory immune tone compared with HC-colonized mice. CONCLUSIONS: We have identified increased fecal proteolytic activity that precedes the clinical diagnosis of UC and associates with gut microbiota changes. This proteolytic signature may constitute a noninvasive biomarker of inflammation to monitor at-risk populations that can be targeted therapeutically with antiproteases.
引用
- Galipeau HJ, Caminero A, Turpin W, et al. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology. 2020. PMID: 33310084. doi:10.1053/j.gastro.2020.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。